Literature DB >> 19174559

Inhibition of cervical cancer cell growth by human papillomavirus virus-like particles packaged with human papillomavirus oncoprotein short hairpin RNAs.

Latifa Bousarghin1, Antoine Touze, Guillaume Gaud, Sophie Iochmann, Eva Alvarez, Pascale Reverdiau, Julien Gaitan, Marie-Lise Jourdan, Pierre-Yves Sizaret, Pierre L Coursaget.   

Abstract

Overexpression of human papillomavirus (HPV E6 and HPV E7) oncogenes in human cervical cells results in the development of cancer, and E6 and E7 proteins are therefore targets for preventing cervical cancer progression. Here, we describe the silencing of E6 and E7 expression in cervical carcinoma cells by RNA interference. In order to increase the efficacy of the RNA interference, HPV pseudovirions coding for a short hairpin RNA (shRNA) sequence were produced. The results indicated the degradation of E6 and E7 mRNAs when shRNA against E6 or E7 were delivered by pseudovirions in HPV-positive cells (CaSki and TC1 cells). E6 silencing resulted in the accumulation of cellular p53 and reduced cell viability. More significant cell death was observed when E7 expression was suppressed. Silencing E6 and E7 and the consequences for cancer cell growth were also investigated in vivo in mice using the capacity of murine TC1 cells expressing HPV-16 E6 and E7 oncogenes to induce fast-growing tumors. Treatment with lentiviruses and HPV virus-like particle vectors coding for an E7 shRNA sequence both resulted in dramatic inhibition of tumor growth. These results show the ability of pseudovirion-delivered shRNA to produce specific gene suppression and provide an effective means of reducing HPV-positive tumor growth.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19174559     DOI: 10.1158/1535-7163.MCT-08-0626

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  17 in total

1.  Human papillomavirus type 16 pseudovirions with few point mutations in L1 major capsid protein FG loop could escape actual or future vaccination for potential use in gene therapy.

Authors:  Maxime J J Fleury; Antoine Touzé; Pierre Coursaget
Journal:  Mol Biotechnol       Date:  2014-05       Impact factor: 2.695

2.  Characterization of an RNA aptamer against HPV-16 L1 virus-like particles.

Authors:  Ana Gabriela Leija-Montoya; María Luisa Benítez-Hess; Julia Dolores Toscano-Garibay; Luis Marat Alvarez-Salas
Journal:  Nucleic Acid Ther       Date:  2014-08-11       Impact factor: 5.486

3.  Knock down of p53 or its ubiquitin ligase E6AP does not affect the sensitivity of human papillomavirus-positive cervical cancer cells to cisplatin.

Authors:  Olga Michnov; Erich Solomayer; Tanja Fehm; Frank Stubenrauch; Thomas Iftner
Journal:  Am J Cancer Res       Date:  2012-04-22       Impact factor: 6.166

4.  Papillomavirus pseudovirions packaged with the L2 gene induce cross-neutralizing antibodies.

Authors:  Nicolas Combelas; Emilie Saussereau; Maxime J J Fleury; Tatiana Ribeiro; Julien Gaitan; Diego F Duarte-Forero; Pierre Coursaget; Antoine Touzé
Journal:  J Transl Med       Date:  2010-03-24       Impact factor: 5.531

5.  Nanoparticles Based on Poly (β-Amino Ester) and HPV16-Targeting CRISPR/shRNA as Potential Drugs for HPV16-Related Cervical Malignancy.

Authors:  Da Zhu; Hui Shen; Songwei Tan; Zheng Hu; Liming Wang; Lan Yu; Xun Tian; Wencheng Ding; Ci Ren; Chun Gao; Jing Cheng; Ming Deng; Rong Liu; Junbo Hu; Ling Xi; Peng Wu; Zhiping Zhang; Ding Ma; Hui Wang
Journal:  Mol Ther       Date:  2018-07-25       Impact factor: 11.454

6.  Human papillomavirus 18 E6 inhibits phosphorylation of p53 expressed in HeLa cells.

Authors:  Amrendra K Ajay; Avtar S Meena; Manoj K Bhat
Journal:  Cell Biosci       Date:  2012-01-13       Impact factor: 7.133

7.  VIRsiRNApred: a web server for predicting inhibition efficacy of siRNAs targeting human viruses.

Authors:  Abid Qureshi; Nishant Thakur; Manoj Kumar
Journal:  J Transl Med       Date:  2013-12-11       Impact factor: 5.531

Review 8.  New molecular targets against cervical cancer.

Authors:  Alfonso Duenas-Gonzalez; Alberto Serrano-Olvera; Lucely Cetina; Jaime Coronel
Journal:  Int J Womens Health       Date:  2014-12-05

Review 9.  IGF axis and other factors in HPV-related and HPV-unrelated carcinogenesis (review).

Authors:  Julia Durzyńska
Journal:  Oncol Rep       Date:  2014-09-19       Impact factor: 3.906

10.  E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines.

Authors:  Liming Li; Cui Xu; Jia Long; Danbei Shen; Wuqing Zhou; Qiyan Zhou; Jia Yang; Mingjun Jiang
Journal:  Oncotarget       Date:  2015-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.